Hyperlipidemia and Cardiovascular Risk Factors in Patients with Type 2 DiabetesByRonald Goldberg, MDAugust 1st 2000
Cost-Effective Management of Type 2 Diabetes: Providing Quality in a Cost-Constrained EnvironmentByBruce Steffens, MDAugust 1st 2000
Thiazolidiones in the Treatment of Type 2 Diabetes: A Clinician's PerspectiveByJohn Buse, MD, PhDAugust 1st 2000